Randomized Phase II Study of Sunitinib versus Standard of Care for Patients with Previously Treated Advanced Triple-Negative Breast Cancer
10.1007/s12035-018-1146-1 160 OhgohM.HanadaT.SmithT.HashimotoT.UenoM.YamanishiY.et al
Current therapeutic strategies primarily focus on the ZIP family of transporters, employing a variety of approaches, including antibody-drug conjugates (ADCs), siRNAs, and natural inhibitors (Table 1)
That article also makes the point that once the bottle is open and living in your home, its smarter to follow the pharmacy label
Patients with untreated rosacea, active acne, or other inflammatory skin conditions often see slower results because the inflammatory environment is counteracting the remodeling signal
Jun 14 2021;doi:10.1002/jcp.30468